Active Ingredient(s):Budesonide + Formoterol Fumarate + Glycopyrrolate FDA Approved: * July 23, 2020 Pharm Company: *ASTRAZENECA AB Category:Lungs (Pulmonary)
Beclometasone/formoterol/glycopyrronium, sold under the brand name Trimbow among others, is an inhalable fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). It contains beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide.
Side effects include oral candidiasis (a fungal infection of the mouth caused by a yeast called Candida), muscle spasms and dry mouth.&...
* May have multiple approval dates, manufacturers, or labelers.